Skip to content ↓

Topic

Developing countries

Download RSS feed: News Articles / In the Media / Audio

Displaying 76 - 82 of 82 news clips related to this topic.
Show:

Bloomberg Businessweek

Peter Coy reports for Bloomberg Businessweek on a new partnership between Saudi Arabia and edX, the online education platform founded by MIT and Harvard. The venture aims to educate Saudi women, youth, disabled, and rural poor, all of whom suffer from high unemployment in the gulf kingdom.

New Scientist

Paul Marks writes for The New Scientist about Protoprint, a company founded by MIT alumnus Sidhant Pai that strives to get decent prices for pickers collecting plastic by repurposing plastic waste for 3D printing. "Our waste-pickers will earn 15 to 20 times more for the same amount of plastic," says Pai.

NPR

Jeremy Hobson interviews Prof. Sangeeta Bhatia about her work 3-D printing tiny human livers on NPR’s Here and Now. The livers are, “about the size of the pin of a needle, and they allow us to do drug testing to test if drugs would be safe when they got into humans,” Bhatia explains. 

Boston Globe

The Boston Globe profiles Dr. Sangeeta Bhatia and the new low-cost urine test she developed to detect cancer, as well as her work applying engineering techniques to medicine.

Reuters

MIT researchers are developing a new more economic and efficient method to filter bacteria from water, reports Yao-Hua Law for Reuters. The new technique could help provide clean water to people in developing countries.  

Wired

Researchers at MIT have developed a new method to diagnosis cancer, writes Liat Clark in Wired. The new technique, which identifies proteins in urine associated with cancer, works like a pregnancy test and could be used to improve cancer care in developing nations, Clark reports. 

WBUR

WBUR reporter Carey Goldberg highlights a new technique developed by MIT researchers, “just out in the Proceedings of the National Academy of Sciences that describes success in diagnosing cancer with a simple, paper-based test — an advance that could be particularly important for the developing countries where 70 percent of cancer deaths now occur.”